Evidence suggests that psilocybin-assisted therapy for those who have not responded to standard interventions may be beneficial.
|Articles|September 6, 2019
- September 2019 Pain Management
- Volume 85
- Issue 9
Evolving Strategies in the Management of HIV: An Update for Pharmacists
New and emerging strategies in the management of HIV
Advertisement
Faculty
Eric K. Farmer, PharmD, BCPS, AAHIVP, HIV Clinical Pharmacist, Indiana University Health, LifeCare Clinic; Indianapolis, Indiana
Educational Objectives
At the completion of this activity, the participant will be able to:
- Explore the burden of HIV and evolving treatment strategies
- Identify current guideline recommendations and therapies, as well as emerging treatment options that may be used to optimize the management of patients with or at risk for HIV
- Examine strategies that pharmacists may employ to improve patient adherence, treatment satisfaction, and overall outcomes
Target audience: Pharmacists
Activity type: Application
Release date: September 16, 2019
Expiration date: September 16, 2020
Estimated time to complete activity: 2.5 hours
Fee: This lesson is offered for free at
Articles in this issue
almost 7 years ago
Keep an Eye on Protein Kinase Inhibitorsalmost 7 years ago
OTC Focus Case Studies: Painalmost 7 years ago
What Are the Options for Treating Pain?almost 7 years ago
Education, Law Enforcement, and Treatment Programs Are Keyabout 7 years ago
Dispensing Mistakes Can Happen to Pets, Tooabout 7 years ago
MRPs Are Both a Blessing and a Curseabout 7 years ago
Pharmacists Can Provide Optimal Migraine Treatmentsabout 7 years ago
Melrose Pharmacy Offers a Unique Feelabout 7 years ago
Topical Analgesics Provide Pain Reliefabout 7 years ago
Case Studies (September 2019)Advertisement
Related to this article
Investigational antiamyloid monoclonal antibodies may offer a novel pathway to disease reversal.
Increasingly, pharmacists are leading the obesity management team.
A panel of cardiology pharmacists discussed the diagnostic red flags, evolving treatment landscape, and expanding pharmacist role central to identifying and managing ATTR-CM.
Weight-based norepinephrine dosing did not improve time to goal MAP, and median dose was similar compared with non–weight-based dosing in patients with septic shock.
The panelists emphasized that selecting a therapy is only one step toward improving outcomes for patients with heart failure.
Pharmacists can educate patients about staying up to date on immunizations and discuss fall prevention strategies.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Nearly Two-Thirds of Patients With Long COVID Meet Diagnostic Criteria for POTS
2
After 180 Years, Multiple Myeloma Gets a Definition of Cure
3
Psilocybin-Assisted Therapy for AUD: Emerging Evidence, Clinical and Cost Implications, and Treatment Gaps
4
Influenza Vaccines Continue to Reduce Severe Disease and Death Across High-Risk Groups, Evidence Review Finds
5